1. Home
  2. ZURA vs BZFD Comparison

ZURA vs BZFD Comparison

Compare ZURA & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • BZFD
  • Stock Information
  • Founded
  • ZURA 2022
  • BZFD 2006
  • Country
  • ZURA United States
  • BZFD United States
  • Employees
  • ZURA N/A
  • BZFD N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • BZFD Movies/Entertainment
  • Sector
  • ZURA Health Care
  • BZFD Consumer Discretionary
  • Exchange
  • ZURA Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • ZURA 69.9M
  • BZFD 76.3M
  • IPO Year
  • ZURA N/A
  • BZFD N/A
  • Fundamental
  • Price
  • ZURA $2.04
  • BZFD $1.96
  • Analyst Decision
  • ZURA Buy
  • BZFD
  • Analyst Count
  • ZURA 10
  • BZFD 0
  • Target Price
  • ZURA $12.67
  • BZFD N/A
  • AVG Volume (30 Days)
  • ZURA 367.0K
  • BZFD 316.5K
  • Earning Date
  • ZURA 08-14-2025
  • BZFD 08-07-2025
  • Dividend Yield
  • ZURA N/A
  • BZFD N/A
  • EPS Growth
  • ZURA N/A
  • BZFD N/A
  • EPS
  • ZURA N/A
  • BZFD 0.25
  • Revenue
  • ZURA N/A
  • BZFD $194,178,000.00
  • Revenue This Year
  • ZURA N/A
  • BZFD $6.87
  • Revenue Next Year
  • ZURA N/A
  • BZFD $6.21
  • P/E Ratio
  • ZURA N/A
  • BZFD $7.87
  • Revenue Growth
  • ZURA N/A
  • BZFD 1.38
  • 52 Week Low
  • ZURA $0.97
  • BZFD $1.61
  • 52 Week High
  • ZURA $5.07
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 65.78
  • BZFD 41.28
  • Support Level
  • ZURA $1.44
  • BZFD $1.95
  • Resistance Level
  • ZURA $2.09
  • BZFD $2.14
  • Average True Range (ATR)
  • ZURA 0.14
  • BZFD 0.09
  • MACD
  • ZURA 0.03
  • BZFD 0.00
  • Stochastic Oscillator
  • ZURA 78.31
  • BZFD 34.31

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: